Transforming growth factor β inhibits steroidogenic acute regulatory (StAR) protein expression in human ovarian thecal cells

被引:21
作者
Attia, GR [1 ]
Dooley, CA [1 ]
Rainey, WE [1 ]
Carr, BR [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol, Dallas, TX 75390 USA
关键词
thecal cell; StAR; TGF beta 1;
D O I
10.1016/S0303-7207(00)00335-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, we investigated the effects of TGF beta1 on steroidogensis and expression of the steroidogenic acute regulatory (StAR) protein which regulates an important early step in the steroidogenic pathway. We utilized a human ovarian thecal like tumor (HOTT) cell model and investigated the effects of activin-A, inhibin-A, or TGF beta1 in the presence of forskolin and the effect of dibutyryl cyclic AMP (dbcAMP) on steroid accumulation in the culture medium. Cells were also treated with different concentration of TGF beta1 in the presence of forskolin, combined steroid production was measured at the end of 48 h and after 3 h incubation with 22R-hydroxycholesterol. In the presence of TGF beta1 there was a dose-dependent inhibition of androstenedione production. Inhibition in combined steroid production was apparent at the highest concentration of TGF beta1 tested. In the presence of 22R-hydroxycholesterol, combined steroid production was significantly inhibited at lower concentrations. TGF beta1 inhibited StAR protein expression in a concentration dependent manner. There was also a similar inhibition in StAR mRNA. These results suggest that the effect of TGF beta1 on steroid production and possibly follicular development may be in part due to its effects on StAR expression. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 24 条
[1]   Smad3 is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-β on StAR expression [J].
Brand, C ;
Souchelnytskiy, S ;
Chambaz, EM ;
Feige, JJ ;
Bailly, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (03) :780-785
[2]   The effect of transforming growth factor-beta on steroidogenesis and expression of key steroidogenic enzymes with a human ovarian thecal-like tumor cell model [J].
Carr, BR ;
McGee, EA ;
Sawetawan, C ;
Clyne, CD ;
Rainey, WE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (04) :1109-1116
[3]  
CARR BR, 1996, SERONO S US, P165
[4]   IMMUNOCYTOCHEMICAL LOCALIZATION OF TRANSFORMING GROWTH-FACTORS (TGFS) TGF-ALPHA AND TGF-BETA IN HUMAN OVARIAN TISSUES [J].
CHEGINI, N ;
WILLIAMS, RS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :973-980
[5]   PRESENCE OF TRANSFORMING GROWTH-FACTOR-BETA AND THEIR SELECTIVE CELLULAR-LOCALIZATION IN HUMAN OVARIAN TISSUE OF VARIOUS REPRODUCTIVE STAGES [J].
CHEGINI, N ;
FLANDERS, KC .
ENDOCRINOLOGY, 1992, 130 (03) :1707-1715
[6]   EPIDERMAL GROWTH-FACTOR ENHANCES OOCYTE MATURATION IN PIGS [J].
DING, JC ;
FOXCROFT, GR .
MOLECULAR REPRODUCTION AND DEVELOPMENT, 1994, 39 (01) :30-40
[7]   Physiologic basis of ovulation induction [J].
Erickson, GF .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1996, 14 (04) :287-297
[8]  
FALCK B, 1959, ACTA PHYSIOL SCAND, V47, P1
[9]   Induction of apoptosis in rat thecal/interstitial cells by transforming growth factor alpha plus transforming growth factor beta in vitro [J].
Foghi, A ;
Teerds, KJ ;
vanderDonk, H ;
Dorrington, J .
JOURNAL OF ENDOCRINOLOGY, 1997, 153 (01) :169-178
[10]  
KOPPA SD, 1994, DRUG THER, V24, P34